OpportunityTitle: NIAMS Clinical Study Implementation Cooperative Agreement (UM1)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.   Foreign (non-U.S.) components of U.S. Organizations are allowed.
Description: This Funding Opportunity Announcement (FOA) issued by the NIAMS invites cooperative agreement (UM1) applications for implementation of investigator-initiated interventional clinical trials (all phases). Applications for clinical trials submitted to the NIAMS are normally expected to go through a two-part process, which begins with a (U34) planning phase (Part 1) followed by an application for the (UM1) clinical trial implementation phase (Part 2). See PAR-11-169 for information about the NIAMS Clinical Trial Planning Cooperative Agreement (U34). Investigators who have completed all necessary pre-trial planning and preparation through other means may also apply for a NIAMS UM1. Consultation with NIAMS staff is strongly encouraged prior to the submission of the clinical trial implementation UM1 application. The NIAMS expects such trials to be hypothesis-driven, milestone-defined, related to the research mission of the NIAMS, and considered high priority by the Institute.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;